" class="no-js "lang="en-US"> Zilia - Pharmtech Focus
Tuesday, January 31, 2023

Breaking News

MedRhythms Feasibility Study Shows Positive Topline Results in Parkinson’s Disease Ionis receives FDA Fast Track designation for Olezarsen in patients with Familial Chylomicronemia Syndrome Sensorion and EVEON Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments Into the Inner Ear Qurient Announces Dosing of First Patient in Clinical Study for the Treatment of Patients with Solid Tumors Marinus Pharmaceuticals Appoints Christine Silverstein to its Board of Directors Bruno Ultra Barcelos is appointed Managing Director of Ethypharm UK Axion BioSystems Launches New High-Throughput Live-Cell Imaging Platform, Omni Pro 12 CHOP Experts Share Cutting-Edge Innovations at Arab Health Exhibition Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR-017 in the Treatment of RRMM in The Lancet Haematology ClariMed Launches Integrated Medical Device Services Partner
Zilia | Pharmtech Focus

Zilia

About Zilia

Zilia

Zilia is a medical device company that provides actionable information based on the measurement of biomarkers in the eye to facilitate earlier diagnosis, reduce healthcare costs, and improve the quality of life of patients.

Related Story

Fundraising

 One Step Closer to Better Ocular Health: Zilia Secures $4 Million in Seed Funding | Pharmtech Focus

One Step Closer to Better Ocular Health: Zilia Secures $4 Million in Seed Funding

August 12 2021

Zilia, a Quebec-based company developing medical technologies for the assessment of biomarkers in the eye, announced […]